Business · 20/05/2003Updated: 10/17/2026 · 1 min read
FDA's Endocrinologic and Metabolic Drugs Advisory Committee to Review Proposed Changes to Diabetes Medication Notice
Summary
The Endocrinologic and Metabolic Drugs Advisory Committee will review proposed amendments to a notice related to diabetes medications, as requested by the FDA